116 related articles for article (PubMed ID: 17696212)
1. On-line sample stacking and short-end injection CE for the determination of fluoxetine and norfluoxetine in plasma: Method development and validation using experimental designs.
Lu CC; Jong YJ; Ferrance J; Ko WK; Wu SM
Electrophoresis; 2007 Sep; 28(18):3290-5. PubMed ID: 17696212
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound-assisted dispersive liquid-liquid microextraction coupled with field-amplified capillary electrophoresis for sensitive and quantitative determination of fluoxetine and norfluoxetine enantiomers in biological fluids.
Wang ZR; Hsieh MM
Anal Bioanal Chem; 2020 Aug; 412(21):5113-5123. PubMed ID: 32162085
[TBL] [Abstract][Full Text] [Related]
3. Micellar electrokinetic capillary chromatography for the determination of fluoxetine and its metabolite norfluoxetine in biological fluids.
Berzas Nevado JJ; Contento Salcedo AM; Villaseñor Llerena MJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Apr; 769(2):261-8. PubMed ID: 11996492
[TBL] [Abstract][Full Text] [Related]
4. Sensitive liquid chromatographic-tandem mass spectrometric method for the determination of fluoxetine and its primary active metabolite norfluoxetine in human plasma.
Sutherland FC; Badenhorst D; de Jager AD; Scanes T; Hundt HK; Swart KJ; Hundt AF
J Chromatogr A; 2001 Apr; 914(1-2):45-51. PubMed ID: 11358229
[TBL] [Abstract][Full Text] [Related]
5. Improved enantioselective assay for the determination of fluoxetine and norfluoxetine enantiomers in human plasma by liquid chromatography.
Gatti G; Bonomi I; Marchiselli R; Fattore C; Spina E; Scordo G; Pacifici R; Perucca E
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Feb; 784(2):375-83. PubMed ID: 12505785
[TBL] [Abstract][Full Text] [Related]
6. Fast separation of selective serotonin reuptake inhibitors antidepressants in plasma sample by nonaqueous capillary electrophoresis.
Catai AP; Carrilho E; Lanças FM; Queiroz ME
J Chromatogr A; 2009 Jul; 1216(30):5779-82. PubMed ID: 19545874
[TBL] [Abstract][Full Text] [Related]
7. Fluoxetine bioequivalence study: quantification of fluoxetine and norfluoxetine by liquid chromatography coupled to mass spectrometry.
Moraes MO; Lerner FE; Corso G; Bezerra FA; Moraes ME; De Nucci G
J Clin Pharmacol; 1999 Oct; 39(10):1053-61. PubMed ID: 10516940
[TBL] [Abstract][Full Text] [Related]
8. Analysis of fluoxetine and norfluoxetine in human plasma by liquid-phase microextraction and injection port derivatization GC-MS.
Oliveira AF; de Figueiredo EC; Dos Santos-Neto AJ
J Pharm Biomed Anal; 2013 Jan; 73():53-8. PubMed ID: 22555013
[TBL] [Abstract][Full Text] [Related]
9. Determination of fluoxetine and norfluoxetine in rat plasma by HPLC with pre-column derivatization and fluorescence detection.
Guo X; Fukushima T; Li F; Imai K
Biomed Chromatogr; 2003 Jan; 17(1):1-5. PubMed ID: 12582998
[TBL] [Abstract][Full Text] [Related]
10. Enantiomeric separation of fluoxetine and norfluoxetine in plasma and serum samples with high detection sensitivity capillary electrophoresis.
Desiderio C; Rudaz S; Raggi MA; Fanali S
Electrophoresis; 1999 Nov; 20(17):3432-8. PubMed ID: 10608711
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous determination of aripiprazole and its active metabolite, dehydroaripiprazole, in plasma by capillary electrophoresis combining on-column field-amplified sample injection and application in schizophrenia.
Hwang PL; Wei SY; Yeh HH; Ko JY; Chang CC; Chen SH
Electrophoresis; 2010 Aug; 31(16):2778-86. PubMed ID: 20665528
[TBL] [Abstract][Full Text] [Related]
12. A validated enantioselective assay for the simultaneous quantitation of (R)-, (S)-fluoxetine and (R)-, (S)-norfluoxetine in ovine plasma using liquid chromatography with tandem mass spectrometry (LC/MS/MS).
Chow TW; Szeitz A; Rurak DW; Riggs KW
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Feb; 879(5-6):349-58. PubMed ID: 21242112
[TBL] [Abstract][Full Text] [Related]
13. Capillary electrophoresis with online stacking in combination with AgNPs@MCM-41 reinforced hollow fiber solid-liquid phase microextraction for quantitative analysis of Capecitabine and its main metabolite 5-Fluorouracil in plasma samples isolated from cancer patients.
Forough M; Farhadi K; Molaei R; Khalili H; Shakeri R; Zamani A; Matin AA
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():22-37. PubMed ID: 27898365
[TBL] [Abstract][Full Text] [Related]
14. Sensitive determination of sertraline by capillary electrophoresis with dispersive liquid-liquid microextraction and field-amplified sample stacking.
Huang SW; Hsieh MM; Chang SY
Talanta; 2012 Nov; 101():460-4. PubMed ID: 23158349
[TBL] [Abstract][Full Text] [Related]
15. Quantification of fluoxetine and norfluoxetine serum levels by reversed-phase high-performance liquid chromatography with ultraviolet detection.
Holladay JW; Dewey MJ; Yoo SD
J Chromatogr B Biomed Sci Appl; 1997 Dec; 704(1-2):259-63. PubMed ID: 9518159
[TBL] [Abstract][Full Text] [Related]
16. Trace analysis of fluoxetine and its metabolite norfluoxetine. Part I: development of a chiral liquid chromatography-tandem mass spectrometry method for wastewater samples.
Barclay VK; Tyrefors NL; Johansson IM; Pettersson CE
J Chromatogr A; 2011 Aug; 1218(33):5587-96. PubMed ID: 21752386
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous determination of fluoxetine and its major active metabolite norfluoxetine in human plasma by LC-MS/MS using supported liquid extraction.
Li Y; Emm T; Yeleswaram S
Biomed Chromatogr; 2011 Nov; 25(11):1245-51. PubMed ID: 21308704
[TBL] [Abstract][Full Text] [Related]
18. Liquid chromatography/tandem mass spectrometry for the determination of fluoxetine and its main active metabolite norfluoxetine in human plasma with deuterated fluoxetine as internal standard.
Li C; Ji Z; Nan F; Shao Q; Liu P; Dai J; Zhen J; Yuan H; Xu F; Cui J; Huang B; Zhang M; Yu C
Rapid Commun Mass Spectrom; 2002; 16(19):1844-50. PubMed ID: 12271449
[TBL] [Abstract][Full Text] [Related]
19. Fluoxetine and norfluoxetine plasma levels after discontinuing fluoxetine therapy.
Brunswick DJ; Amsterdam JD; Fawcett J; Quitkin FM; Reimherr FW; Rosenbaum JF; Beasley CM
J Clin Psychopharmacol; 2001 Dec; 21(6):616-8. PubMed ID: 11763012
[No Abstract] [Full Text] [Related]
20. Issues in methodology and applications for therapeutic drug monitoring of fluoxetine and norfluoxetine enantiomers.
Zuccaro P; Pacifici R; Altieri I; Avenoso A; Pellegrini M; Spina E; Perucca E; Pichini S
Ther Drug Monit; 1998 Feb; 20(1):20-4. PubMed ID: 9485549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
